Moderna
Pfizer
Covid-19
Biotech
The stock prices of some of the most well-known companies in the biotech industry changed on Wednesday as a result of news that surfaced. Yesterday, Moderna’s share price increased after it was revealed that the company would continue working on the development of a cancer vaccine. Following the FDA’s approval of its booster doses for younger minors, Pfizer, an industry rival, also enjoyed an increase in its share price.
Pfizer Stock and Moderna
Moderna’s Cancer Immunization
The COVID-19 period has seen a stratospheric increase for Moderna (MRNA), with its share price exceeding $486 on August 9th, 2021. This Massachusetts-based biotech business benefited from the global trend of governments pursuing vaccine remedies for their people.
doltd.blog 